Edition:
United States

Ironwood Pharmaceuticals Inc (IRWD.OQ)

IRWD.OQ on NASDAQ Stock Exchange Global Select Market

11.75USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$11.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
400,478
52-wk High
$21.19
52-wk Low
$11.03

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 65.69 -1.138
Jun '18 81.11 -0.325
Mar '18 69.15 -0.286
FY 2017 Dec '17 94.21 0.080
Sep '17 86.82 -0.216
Jun '17 65.08 -0.297
Mar '17 52.17 -0.355
FY 2016 Dec '16 87.46 -0.092
Sep '16 66.11 -0.229
Jun '16 54.35 -0.150
Mar '16 66.04 -0.093
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 10 96.78 105.00 89.50 99.53
Quarter Ending Mar-19 5 87.08 106.10 63.70 --
Year Ending Dec-18 11 318.68 348.52 305.00 372.83
Year Ending Dec-19 12 377.62 474.68 311.00 478.10
Earnings (per share)
Quarter Ending Dec-18 7 -0.16 -0.08 -0.21 0.02
Quarter Ending Mar-19 2 -0.04 0.10 -0.18 --
Year Ending Dec-18 7 -1.03 -0.72 -1.14 -0.52
Year Ending Dec-19 7 0.01 0.53 -0.47 0.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta 1.24 0.66 0.95
Price to Sales (TTM) 6.49 242.95 21.76
Price to Book (MRQ) -- 18.87 4.53
Price to Tangible Book (MRQ) -- 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -24.35 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago 6.39 61.53 5.26
Sales - 5 Yr. Growth Rate 14.70 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -426.71 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago -73.60 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate -21.33 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.21 3.57 2.63
Current Ratio (MRQ) 2.21 6.87 3.68
LT Debt to Equity (MRQ) -- 16.70 9.53
Total Debt to Equity (MRQ) -- 21.89 13.39
Interest Coverage (TTM) -3.11 -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 93.46 31.33 50.91
Gross Margin - 5 Yr. Avg. 93.45 47.59 52.22
EBITD Margin (TTM) -11.81 -- --
EBITD - 5 Yr. Avg -69.76 -141.70 16.27
Operating Margin (TTM) -71.62 -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -79.74 -155.53 11.89
Pre-Tax Margin (TTM) -82.15 -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -97.89 -157.11 12.22
Net Profit Margin (TTM) -82.15 -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -97.89 -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 424,870 28,103,806 878,349,382
Net Income/Employee (TTM) -349,027 -3,710,889 102,474,711
Receivable Turnover (TTM) 4.26 9.19 5.49
Inventory Turnover (TTM) 73.05 2.64 3.99
Asset Turnover (TTM) 0.60 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.92 0.35 11.06
Return on Assets - 5 Yr. Avg. -34.13 2.90 11.85
Return on Investment (TTM) -58.93 0.60 13.80
Return on Investment - 5 Yr. Avg. -39.68 2.87 15.17
Return on Equity (TTM) -- -2.18 15.29
Return on Equity - 5 Yr. Avg. -219.86 -0.88 16.29
  1 Year 3 Year 5 Year
Sales % 8.88 57.44 14.70
EPS (TTM) % -39.21 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ironwood Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -0.83 -0.82 99 99
13 Week -29.96 -24.33 63 94
26 Week -22.02 -21.79 98 96
52 Week -19.52 -21.94 99 98
YTD -12.81 -13.09 99 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 223
Total Shares Held: 150,557,878
3 Mo. Net Change: -4,624,171
# New Positions: 25
# Closed Positions: 21
# Increased Positions: 94
# Reduced Positions: 89
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.